The phrase "a suitable compound for" is correct and usable in written English.
It can be used when discussing the appropriateness of a chemical compound for a specific application or purpose.
Example: "This research paper evaluates a suitable compound for enhancing the efficiency of solar cells."
Alternatives: "an appropriate compound for" or "a fitting compound for".
A suitable compound for the treatment of normal tension glaucoma should at least act hemodynamically neutral.
In rich growth media, cladosporin displays a 30% inhibitory concentration (IC30) of 110 μM, making it a suitable compound for haploinsufficiency profiling (HIP) assay (Giaever et al., 1999).
While it is unknown whether inhibition of either of the C. elegans NTE homologs will induce an OPIDP-like condition, the syndrome has been described in humans following dichlorvos exposure (reviewed in [ 28]) raising the possibility that dichlorvos might be a suitable compound for investigating this effect.
In this present work, we find that ammonium hexafluorotitanate is the most suitable compound for Ti doping and for controlled structural morphology.
Our data indicate that among the peptides tested, the BN5/BN8 pair with the NMeGly11 and Sta13-Leu14 substitutions would be the most suitable compound for rapid high-contrast GRP-R targeting for imaging applications in vivo.
Despite this obstacle, we utilized NBS labeling since it was the only suitable compound for the detecting of solvent-exposed tryptophans.
However, in the current era of genomics and metagenomics, finding and characterizing FAEs is not straightforward, mainly due to a lack of suitable compounds for high-throughput assays.
Suitable compounds for this purpose would be a nonmetabolisable such as sucrose or xylose or one such as ribose or fructose which is metabolisable at normal physiological concentrations.
Thus, although initial data demonstrate that α v β6-specific imaging is feasible, further optimizations are needed to find suitable compounds for noninvasive imaging of this receptor in patients.
Compound 11 therefore represents a suitable lead compound for future drug development projects, due to its novel conformationally constrained structure, its "lead-like" properties and desirable affinity, efficacy and selectivity characteristics.
With very good pharmacokinetic properties and no major safety alerts, compound 12 was identified as a suitable tool compound for further in vivo investigations.
